TWI680431B - Interactive intelligent health management system and method - Google Patents
Interactive intelligent health management system and method Download PDFInfo
- Publication number
- TWI680431B TWI680431B TW106146583A TW106146583A TWI680431B TW I680431 B TWI680431 B TW I680431B TW 106146583 A TW106146583 A TW 106146583A TW 106146583 A TW106146583 A TW 106146583A TW I680431 B TWI680431 B TW I680431B
- Authority
- TW
- Taiwan
- Prior art keywords
- data
- health
- user
- medical
- database
- Prior art date
Links
- 230000036541 health Effects 0.000 title claims abstract description 154
- 230000002452 interceptive effect Effects 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title description 7
- 238000004458 analytical method Methods 0.000 claims abstract description 36
- 238000011156 evaluation Methods 0.000 claims abstract description 31
- 238000012360 testing method Methods 0.000 claims abstract description 30
- 230000002068 genetic effect Effects 0.000 claims abstract description 27
- 238000007726 management method Methods 0.000 claims abstract description 27
- 230000002159 abnormal effect Effects 0.000 claims abstract description 16
- 201000010099 disease Diseases 0.000 claims description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 31
- 208000024891 symptom Diseases 0.000 claims description 10
- 238000012502 risk assessment Methods 0.000 claims description 9
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- 230000002776 aggregation Effects 0.000 claims description 3
- 238000004220 aggregation Methods 0.000 claims description 3
- 238000007405 data analysis Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 description 7
- 208000017169 kidney disease Diseases 0.000 description 6
- 230000002485 urinary effect Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 102000017919 ADRB2 Human genes 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 102000013830 Calcium-Sensing Receptors Human genes 0.000 description 1
- 108010050543 Calcium-Sensing Receptors Proteins 0.000 description 1
- 101000959437 Homo sapiens Beta-2 adrenergic receptor Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
一種互動式智能健康管理方法包含下列步驟：首先，使用者登入使用者介面平台，接著，該使用者將需求提問輸入至需求資料介面，然後，該使用者介面平台對該使用者之需求提問與個人化資料庫進行異常比對，以得到健康分析資料，而該個人化資料庫儲存有該使用者進行基因檢測所得之檢測結果、該使用者的日常健康數據，及該使用者的醫療數據，接著，該使用者介面平台對該使用者之需求提問與醫學與健康資料庫進行相關比對，以得到醫學相關資料，最後，該使用者介面平台對該健康分析資料與該醫學相關資料進行相關比對，以得到評估建議報告。 An interactive intelligent health management method includes the following steps: first, a user logs in to a user interface platform, then the user enters a demand question into a demand data interface, and then the user interface platform asks the user's demand and The personalization database performs abnormal comparison to obtain health analysis data, and the personalization database stores the test results obtained by the user's genetic testing, the user's daily health data, and the user's medical data, Then, the user interface platform compares the user's needs and questions with the medical and health database to obtain medical related data. Finally, the user interface platform correlates the health analysis data with the medical related data. Compare to get evaluation report.
Description
本發明是有關一種健康管理系統，特別是指一種互動式智能健康管理系統及其方法。 The invention relates to a health management system, in particular to an interactive intelligent health management system and method.
基因影響人類的發展與疾病甚鉅，基因表現可能在人體上引發的現象已經是目前醫學全力鑽研的對象，透過基因檢測能幫助了解我們的先天體質與先天健康風險，以達到促進健康、預防疾病之目的。 Genes have a huge impact on human development and diseases. The phenomenon that genetic expression may cause on the human body is already the object of full medical research. Through genetic testing, we can help understand our innate constitution and innate health risks to achieve health promotion and disease prevention. Purpose.
但是我們的健康不僅僅是由基因決定，常見疾病及病狀之病源學通常歸因於基因及環境因子，健康風險的評估若無生活環境型態的考量，將難以準確、可靠地反映整體健康狀態，故先天基因資訊結合後天生活環境型態可提供更完整全面的健康管理評估，有助於生活品質的提升，並同時減少醫療資源的浪費。 But our health is not only determined by genes. The etiology of common diseases and conditions is usually attributed to genes and environmental factors. Without the consideration of living environment type, it will be difficult to accurately and reliably reflect overall health. Status, so innate genetic information combined with acquired living environment patterns can provide a more complete and comprehensive health management assessment, help improve the quality of life, and reduce waste of medical resources.
隨著穿戴裝置的普及，使用者於配戴時可偵測心跳速度、體溫、血壓等生理資訊，並藉由無線傳輸至攜帶式電子裝置進行紀錄與顯示，然而，該等紀錄資料令使用者只能被動地的受制於少數生理資訊或生理參數來評估是否需改變飲食、作息，無法回饋使用者即時的健康建議或疾病評估，往往因此延誤了給藥、就醫或早期發現 治療的時機。 With the popularization of wearable devices, users can detect physiological information such as heartbeat speed, body temperature, and blood pressure when wearing, and wirelessly transmit to portable electronic devices for recording and display. However, such record data makes users It can only be passively limited by a small amount of physiological information or physiological parameters to assess whether it is necessary to change diet, schedule, and can not give users immediate health advice or disease assessment, which often delays medication, medical treatment or early detection. Timing of treatment.
上述缺點都顯現習知健康管理與評估在使用上所衍生的種種問題，該等健康管理系統僅能針對使用者的生理資訊進行簡單的判斷，告知使用者目前的生理狀況，但無法針對較多或長期的醫療數據進行分析，以提供個人化的健康建議或疾病風險評估，因此，現有技術確實有待提出更佳解決方案之必要性。 The above shortcomings all show various problems arising from the use of conventional health management and evaluation. These health management systems can only make simple judgments on the user's physiological information and inform the user of the current physiological condition, but cannot address more Or long-term medical data is analyzed to provide personalized health advice or disease risk assessment. Therefore, the existing technology really needs to propose a better solution.
有鑑於此，本發明之目的，是提供一種互動式智能健康管理方法，該方法包含下列步驟。 In view of this, an object of the present invention is to provide an interactive intelligent health management method, which includes the following steps.
首先，使用者登入一使用者介面平台，接著，該使用者將需求提問輸入至一需求資料介面，最後，該使用者介面平台對該使用者之需求提問與一個人化資料庫及一醫學與健康資料庫進行比對，以得到一評估建議報告供該使用者參考，其中，該個人化資料庫中儲存有該使用者進行基因檢測所得之檢測結果、該使用者的日常健康數據，及該使用者的醫療數據，而該醫學與健康資料庫中儲存有醫學與健康相關資料。 First, a user logs into a user interface platform, then the user enters a demand question into a demand data interface, and finally, the user interface platform asks the user's demand question with a personalized database and a medicine and health The database is compared to obtain an evaluation recommendation report for the user's reference. The personalized database stores the test results obtained by the user's genetic testing, the user's daily health data, and the use. Medical data of a person, and the medical and health database stores medical and health-related data.
本發明的另一技術手段，是在於上述之使用者介面平台對該使用者之需求提問與該個人化資料庫進行異常比對，以得到一健康分析資料，同時該使用者介面平台對該使用者之需求提問與該醫學與健康資料庫進行相 關比對，以得到一醫學相關資料，該使用者介面平台將該健康分析資料與該醫學相關資料進行相關比對，以得到該評估建議報告。 Another technical means of the present invention is that the above-mentioned user interface platform performs an abnormal comparison of the user's demand question with the personalized database to obtain a health analysis data, and at the same time, the user interface platform uses the The needs of the person are compared with the medical and health database The comparison is performed to obtain medical-related data, and the user interface platform compares the health analysis data with the medical-related data to obtain the evaluation recommendation report.
本發明的又一技術手段，是在於上述之使用者介面平台對該使用者之需求提問與該個人化資料庫進行異常比對，以得到一健康分析資料，該使用者介面平台將該健康分析資料與該醫學與健康資料庫進行相關比對，以得到該評估建議報告。 Another technical means of the present invention is that the above-mentioned user interface platform performs an abnormal comparison of the user's demand question with the personalized database to obtain a health analysis data, and the user interface platform analyzes the health analysis. The data are compared with the medical and health database to obtain the evaluation recommendation report.
本發明的再一技術手段，是在於上述之評估建議報告記錄有該使用者可能罹患之疾病風險評估、根據該疾病風險評估中可能罹患之疾病的病徵說明，及根據該病徵說明提供該使用者專屬的個人化健康建議，而該個人化健康建議記錄有醫療、營養品、藥品，及運動器材等配方建議。 Still another technical means of the present invention is that the above-mentioned evaluation recommendation report records a risk assessment of the disease that the user may suffer from, a description of the symptoms of the disease that may suffer from the disease risk assessment, and the user is provided according to the description of the symptoms Exclusive personalised health advice, which contains formula advice for medical, nutritional, pharmaceutical, and sports equipment.
本發明的另一技術手段，是在於上述之健康分析資料是將該使用者可能罹患之疾病列出且作出權重比例分析。 Another technical means of the present invention is that the above-mentioned health analysis data is to list and analyze the weight ratio of the diseases that the user may suffer.
本發明的又一技術手段，是在於該使用者可由該評估建議報告之個人化健康建議連結至一解決方案平台，以直接交易該個人化健康建議之配方建議。 Another technical means of the present invention is that the user can link the personalized health advice of the evaluation recommendation report to a solution platform to directly trade the formula advice of the personalized health advice.
本發明的再一技術手段，是在於上述之日常健康數據是透過一外部穿戴裝置偵測該使用者的生理資 訊數據，而該醫療數據則記錄有該使用者的健檢與看診資訊。 Yet another technical means of the present invention is that the above-mentioned daily health data is detected by an external wearable device of the user's physiological resources. Data, and the medical data records the user's medical examination and consultation information.
本發明的另一技術手段，是在於上述之異常比對係指將該需求提問的關鍵字與該使用者的異常生理數據進行資料比對，而相關比對係指將該需求提問的關鍵字與該健康分析資料及該醫學相關資料進行資料過濾、資料分析，以及資料彙整等作業。 Another technical means of the present invention is that the above-mentioned abnormal comparison refers to a data comparison of the keyword for which the question is asked with the abnormal physiological data of the user, and the related comparison refers to the keyword for which the question is asked Perform data filtering, data analysis, and data aggregation with the health analysis data and the medical related data.
本發明的又一技術手段，是在於上述之需求資料介面設置有文字欄位與語音欄位，且該文字欄位更具有複數健康諮詢選項標籤供使用者選用。 Another technical means of the present invention is that the above-mentioned demand data interface is provided with a text field and a voice field, and the text field further has a plurality of health consultation option labels for users to select.
本發明的再一技術手段，是在於上述之個人化資料庫中的基因檢測結果、該日常健康數據，及該醫療數據的權重配比為該基因檢測結果大於該醫療數據，該醫療數據大於該日常健康數據。 Another technical means of the present invention is that the weighted ratio of the genetic test results, the daily health data, and the medical data in the above-mentioned personalized database is that the genetic test result is greater than the medical data, and the medical data is greater than the Daily health data.
本發明的另一技術手段，是在於上述之個人化資料庫中的基因檢測結果、該日常健康數據，及該醫療數據的權重配比為該基因檢測結果、該醫療數據大於該日常健康數據。 Another technical means of the present invention is that the weighted ratio of the genetic test results, the daily health data, and the medical data in the aforementioned personalization database is the genetic test results, and the medical data is greater than the daily health data.
本發明之又一目的，即在提供一種互動式智能健康管理系統，其包含一使用者介面平台、一需求資料庫、一個人化資料庫、一醫學與健康資料庫，及一評估資料庫。 Another object of the present invention is to provide an interactive intelligent health management system, which includes a user interface platform, a requirements database, a personalized database, a medical and health database, and an evaluation database.
該使用者介面平台可供使用者登入，該需求資料庫與該使用者介面平台連接，包括一供使用者填寫需求提問之需求資料介面，及一與該需求資料介面連接以儲存該需求提問的需求提問單，該個人化資料庫與該使用者介面平台及該需求資料庫連接，並儲存有該使用者的基因檢測結果、該使用者的日常健康數據，及該使用者的歷史醫療數據，該醫學與健康資料庫與該使用者介面平台及該需求資料庫連接，儲存有醫學與健康相關資料，該評估資料庫儲存有對應不同需求提問進行比對所得之健康分析資料、醫學相關資料，以及評估建議報告。 The user interface platform can be used by a user to log in. The requirements database is connected to the user interface platform, and includes a requirements data interface for users to fill in demand questions and a connection to the requirements data interface to store the demand questions. Demand questionnaire, the personalized database is connected with the user interface platform and the demand database, and stores the user's genetic test results, the user's daily health data, and the user's historical medical data, The medical and health database is connected to the user interface platform and the demand database, and stores medical and health-related data. The evaluation database stores health analysis data and medical-related data obtained by comparing questions for different needs. And evaluation report.
本發明的再一技術手段，是在於上述之互動式智能健康管理系統更包含一與該使用者介面平台及該評估資料庫連接之解決方案平台，其包括一儲存有醫療、營養品、藥品，及運動器材的配方資料庫。 Yet another technical means of the present invention is that the above-mentioned interactive intelligent health management system further includes a solution platform connected to the user interface platform and the evaluation database, which includes a medical, nutritional, and pharmaceutical product. And sports equipment formula database.
本發明的另一技術手段，是在於上述之使用者介面平台更包括一反饋介面，該反饋介面係提供使用者與服務人員回饋與回應問題。 Another technical means of the present invention is that the above-mentioned user interface platform further includes a feedback interface, which provides users and service personnel with feedback and response questions.
本發明之有益功效在於，藉由將該需求提問的關鍵字分別與該個人化資料庫及該醫學與健康資料庫進行第一次資料比對，其中，該個人化資料庫集結了該使用者的基因檢測結果、該日常健康數據，及該醫療數據等資料，以搜尋出與使用者自身狀況最有可能之原因，再將 兩者所得之結果進行第二次資料比對，以作出多面向考量且專屬該使用者的健康評估報告，提升早期發現而免於延誤治療之時機，以達智能健康管理之目的。 A beneficial effect of the present invention is that the first time data comparison is performed with the personalization database and the medical and health database respectively by using the keywords of the demand question, wherein the personalization database aggregates the user The genetic test results, the daily health data, and the medical data to search for the most likely reason for the user ’s own condition, and then The results obtained by the two are compared for the second time to make a multi-faceted and exclusive health assessment report for the user, to improve early detection and avoid delay in treatment, to achieve the purpose of intelligent health management.
1‧‧‧使用者介面平台 1‧‧‧user interface platform
11‧‧‧反饋介面 11‧‧‧Feedback Interface
2‧‧‧需求資料庫 2‧‧‧Requirement database
21‧‧‧需求資料介面 21‧‧‧ demand data interface
22‧‧‧需求提問單 22‧‧‧Requirement Questionnaire
3‧‧‧個人化資料庫 3‧‧‧ Personalized Database
31‧‧‧基因檢測結果 31‧‧‧genetic test results
32‧‧‧日常健康數據 32‧‧‧ Daily Health Data
33‧‧‧醫療數據 33‧‧‧ Medical Data
4‧‧‧醫學與健康資料庫 4‧‧‧ Medical and Health Database
41‧‧‧醫學與健康相關資料 41‧‧‧ Medical and Health Related Materials
5‧‧‧評估資料庫 5‧‧‧ Assessment Database
51‧‧‧健康分析資料 51‧‧‧ Health Analysis Data
52‧‧‧醫學相關資料 52‧‧‧ Medical Related Materials
53‧‧‧評估建議報告 53‧‧‧ Evaluation Recommendation Report
531‧‧‧疾病風險評估 531‧‧‧ Disease Risk Assessment
532‧‧‧病徵說明 532‧‧‧ Explanation of symptoms
533‧‧‧個人化健康建議 533‧‧‧personalized health advice
6‧‧‧解決方案平台 6‧‧‧Solution Platform
61‧‧‧配方資料庫 61‧‧‧ recipe database
A‧‧‧外部穿戴裝置 A‧‧‧External Wear Device
91~96‧‧‧步驟 91 ~ 96‧‧‧ steps
圖1是一方塊示意圖，說明本發明互動式智能健康管理系統之較佳實施例；圖2是一方塊示意圖，說明本較佳實施例中一評估建議報告的架構；及圖3是一示意圖，說明本發明互動式智能健康管理方法的步驟流程。 FIG. 1 is a block diagram illustrating a preferred embodiment of the interactive intelligent health management system of the present invention; FIG. 2 is a block diagram illustrating the structure of an evaluation recommendation report in the preferred embodiment; and FIG. 3 is a schematic diagram, The steps and processes of the interactive intelligent health management method of the present invention will be described.
有關本發明之相關申請專利特色與技術內容，在以下配合參考圖式之較佳實施例的詳細說明中，將可清楚的呈現。 The features and technical contents of the related patent application of the present invention will be clearly presented in the following detailed description of the preferred embodiments with reference to the drawings.
參閱圖1、2，為本發明互動式智能健康管理系統及其方法的較佳實施例，該互動式智能健康管理系統，包含一使用者介面平台1、一需求資料庫2、一個人化資料庫3、一醫學與健康資料庫4、一評估資料庫5，及一解決方案平台6。 1 and 2 are preferred embodiments of the interactive intelligent health management system and method of the present invention. The interactive intelligent health management system includes a user interface platform 1, a requirements database 2, and a personalized database. 3. A medical and health database 4, an assessment database 5, and a solution platform 6.
該使用者介面平台1可供使用者登入，其中，該使用者介面平台1更包括一反饋介面11，該反饋介 面11係提供使用者與服務人員回饋與回應問題。 The user interface platform 1 can be used by a user to log in. The user interface platform 1 further includes a feedback interface 11. The feedback interface Face 11 is to provide users and service personnel with feedback and response questions.
該需求資料庫2與該使用者介面平台1連接，包括一供使用者填寫需求提問之需求資料介面21，及一與該需求資料介面21連接以儲存該需求提問的需求提問單22。 The demand database 2 is connected to the user interface platform 1 and includes a demand data interface 21 for users to fill in demand questions, and a demand question list 22 connected to the demand data interface 21 to store the demand questions.
其中，該需求資料介面21設置有文字欄位與語音欄位，以符合不同使用者的使用習慣，且該文字欄位更具有複數健康諮詢選項標籤供使用者選用。實際實施時，健康諮詢選項標籤之內容亦可設定為健康徵狀、飲食營養需求、醫療常識、日常生活或運動習慣等以供使用者直接選用。 The demand data interface 21 is provided with a text field and a voice field to meet the usage habits of different users, and the text field has multiple health consultation option labels for users to choose from. In actual implementation, the content of the health consultation option label can also be set as health symptoms, dietary nutritional requirements, medical common sense, daily life or exercise habits, etc. for users to choose directly.
該個人化資料庫3與該使用者介面平台1及該需求資料庫2連接，並儲存有該使用者的基因檢測結果31、該使用者的日常健康數據32，及該使用者的歷史醫療數據33等資料。 The personalized database 3 is connected to the user interface platform 1 and the demand database 2 and stores the user's genetic test results 31, the user's daily health data 32, and the user's historical medical data 33 and other information.
其中，該基因檢測結果31之基因檢測有眾多項目，例如高血壓基因分析，其有助於了解先天體質與先天健康風險，該日常健康數據32是透過一外部穿戴裝置A偵測該使用者的生理資訊數據，例如呼吸、心跳、血壓、體溫、攝取食物之卡路里、睡眠狀況等即時動態數據，而該醫療數據33則記錄有該使用者的健檢與看診資訊等臨床上的生化檢測項目，例如總膽固醇、三酸甘油脂、血管 硬化指數等數據。 Among them, there are many items for the gene test of the gene test result 31, such as hypertension gene analysis, which helps to understand the innate constitution and innate health risks. The daily health data 32 is used to detect the user through an external wearable device A Physiological information data, such as real-time dynamic data such as breathing, heartbeat, blood pressure, body temperature, calories ingested food, sleep status, etc., and the medical data 33 records clinical biochemical test items such as the user's health check and consultation information , Such as total cholesterol, triglycerides, blood vessels Hardening index and other data.
該醫學與健康資料庫4與該使用者介面平台1及該需求資料庫2連接，儲存有醫學與健康相關資料41，例如由醫學教科書、文獻、各科醫師臨床診斷建議資料等專業醫學資料、疾病資料、醫療知識、營養建議、日常生活及運動習慣建議、醫療追蹤建議等等。 The medical and health database 4 is connected to the user interface platform 1 and the demand database 2 and stores medical and health-related data 41, such as professional medical data such as medical textbooks, literature, and clinical diagnosis recommendations of physicians, Disease information, medical knowledge, nutrition advice, daily life and exercise habits advice, medical tracking advice, and more.
該評估資料庫5儲存有對應不同需求提問進行比對所得之健康分析資料51、醫學相關資料52，以及評估建議報告53，於此，該健康分析資料51為需求提問與該個人化資料庫3進行異常比對所得，該醫學相關資料52為該使用者之需求提問與該醫學與健康資料庫4進行相關比對所得，而該評估建議報告53為該健康分析資料51與該醫學相關資料52進行相關比對所得。 The evaluation database 5 stores health analysis data 51, medical-related data 52, and evaluation suggestion reports 53 obtained by comparing different needs for questioning. Here, the health analysis data 51 is a demand question and the personalized database 3 Obtained through abnormal comparison, the medical related data 52 is the user's needs and questions, and the medical and health database 4 is obtained by the related comparison, and the evaluation recommendation report 53 is the health analysis data 51 and the medical related data 52 Relevant comparison results.
進一步地，該健康分析資料51是將該使用者可能罹患之疾病列出且作出權重比例分析。下表1為本發明之健康分析資料51的權重計算範例，其中該基因檢測結果31權重為2，低、中、高風險計分分別為1、2、3分，該醫療數據33權重為3，數值正常計分為0，異常計分則為3，而該日常健康數據32權重為1，數值正常計分為0，異常計分為3，再以總得分順序由高至低排列出可能罹患之疾病的順序，以得到疾病的權重比例分析。 Further, the health analysis data 51 is a list of diseases that the user may suffer from and a weight ratio analysis is performed. The following table 1 is a weight calculation example of the health analysis data 51 of the present invention. The genetic test result 31 has a weight of 2, the low, medium, and high risk scores are 1, 2, and 3, and the medical data 33 has a weight of 3. , The normal score is 0, the abnormal score is 3, and the daily health data 32 is 1. The normal score is 0, the abnormal score is 3, and the possible scores are ranked from highest to lowest. The order of the illnesses is analysed in order to obtain a weighted proportion of the illnesses.
其中，該評估建議報告53記錄有該使用者可能罹患之疾病風險評估531、根據該疾病風險評估531中可能罹患之疾病的病徵說明532，及根據該病徵說明532提供該使用者專屬的個人化健康建議533，而該個人化健康建議533記錄有醫療、營養品、藥品，及運動器材等配方建議。 Among them, the assessment recommendation report 53 records the risk assessment of the disease that the user may suffer from, 531, the description of the symptoms of the disease that may be affected by the disease risk assessment 531, and the user-specific personalization according to the disease description. Health advice 533, and this personalised health advice 533 records medical, nutritional, pharmaceutical, and sports equipment formulation advice.
該解決方案平台6與該使用者介面平台1及該評估資料庫5連接，其包括一儲存有醫療、營養品、藥品，及運動器材等資訊的配方資料庫61。 The solution platform 6 is connected to the user interface platform 1 and the evaluation database 5 and includes a formula database 61 that stores medical, nutritional, pharmaceutical, and sports equipment information.
配合參閱圖3，依據上述之互動式智能健康管理系統，本發明互動式智能健康管理方法包含下列步驟。 With reference to FIG. 3, according to the above-mentioned interactive intelligent health management system, the interactive intelligent health management method of the present invention includes the following steps.
首先，進行步驟91，使用者登入該使用者介面平台1，接著，進行步驟92，該使用者將需求提問輸入至該需求資料介面21，於此需求提問以疾病或健康管理 等相關問題為主，並作出該需求提問單22儲存於該需求資料庫2中。值得一提的是，該使用者除了可透過該反饋介面11與服務人員直接進行溝通外，更可於該需求資料介面21上詢問自身的需求提問，以提昇互動溝通之即時性。 First, go to step 91, the user logs in to the user interface platform 1, and then, go to step 92, the user enters a demand question into the demand data interface 21, where the demand question is for disease or health management And other related questions are mainly made, and the demand questionnaire 22 is made and stored in the demand database 2. It is worth mentioning that, in addition to communicating directly with service personnel through the feedback interface 11, the user can also ask his own questions on the demand data interface 21 to improve the instantaneity of interactive communication.
然後，進行步驟93，該使用者介面平台1對該使用者之需求提問與該個人化資料庫3進行異常比對，以得到該健康分析資料51，其中，該個人化資料庫5中儲存有該使用者進行基因檢測所得之基因檢測結果31、該使用者的日常健康數據32，及該使用者的醫療數據33。 Then, step 93 is performed. The user interface platform 1 abnormally compares the user's needs and questions with the personalized database 3 to obtain the health analysis data 51. The personalized database 5 stores The genetic test result 31 obtained by the user performing the genetic test, the daily health data 32 of the user, and the medical data 33 of the user.
進一步地，該個人化資料庫3中的基因檢測結果31、該日常健康數據32，及該醫療數據33的權重配比為該基因檢測結果31大於該醫療數據33，該醫療數據33大於該日常健康數據32，亦可為該基因檢測結果31、該醫療數據33大於該日常健康數據32，端視使用需求而定，不應以此為限。 Further, the weighting ratio of the genetic test result 31, the daily health data 32, and the medical data 33 in the personalized database 3 is that the genetic test result 31 is greater than the medical data 33, and the medical data 33 is greater than the daily The health data 32 may also be the genetic test result 31, and the medical data 33 is greater than the daily health data 32, depending on the use needs, and should not be limited to this.
接著，進行步驟94，該使用者介面平台1對該使用者之需求提問與該醫學與健康資料庫4之醫學與健康相關資料41進行相關比對，以得到該醫學相關資料52。 Next, step 94 is performed. The user interface platform 1 performs a relevant comparison with the user's demand question and the medical and health related data 41 of the medical and health database 4 to obtain the medical related data 52.
然後，進行步驟95，該使用者介面平台1對該健康分析資料51與該醫學相關資料52進行相關比 對，以得到該評估建議報告53供該使用者參考。 Then, step 95 is performed. The user interface platform 1 performs a correlation comparison between the health analysis data 51 and the medical related data 52. Yes, to get the evaluation recommendation report 53 for the user's reference.
其中，異常比對係指將該需求提問的關鍵字與該使用者的異常生理數據進行資料比對，而相關比對係指將該需求提問的關鍵字與該健康分析資料51及該醫學相關資料52進行資料過濾、資料分析，以及資料彙整等作業。 Among them, abnormal comparison refers to a data comparison between the keyword of the question and the abnormal physiological data of the user, and correlation comparison refers to a relationship between the keyword of the question and the health analysis data 51 and the medicine. Data 52 performs operations such as data filtering, data analysis, and data aggregation.
藉由將該需求提問的關鍵字分別與該個人化資料庫3及該醫學與健康資料庫4進行第一次資料比對，再將兩者所得之結果進行第二次資料比對，以作出多面向且專屬該使用者的健康評估報告，提升早期發現而免於延誤治療之時機，以達智能健康管理之目的。 By comparing the keywords of the demand question with the personalized database 3 and the medical and health database 4 respectively for the first data comparison, and then the results obtained by the two are compared with the second data to make The multi-faceted and exclusive health assessment report of the user improves the early detection without delaying the treatment, so as to achieve the purpose of intelligent health management.
特別說明的是，資料比對的順序亦可為該使用者介面平台1對該使用者之需求提問與該個人化資料3庫進行異常比對，以得到該健康分析資料51，該使用者介面平台1將該健康分析資料51與該醫學與健康資料庫之醫學與健康相關資料41進行相關比對，而得到該評估建議報告53，進而獲取不同比對資料量。 In particular, the order of data comparison can also be the user interface platform 1 asking the user's needs and performing an abnormal comparison with the personalized data 3 library to obtain the health analysis data 51, the user interface The platform 1 compares the health analysis data 51 with the medical and health-related data 41 of the medical and health database, and obtains the evaluation recommendation report 53 to obtain different comparison data amounts.
最後，進行步驟96，該使用者可由該評估建議報告53之個人化健康建議533連結至該解決方案平台6，以直接交易該個人化健康建議533之配方建議，於此，該配方建議可以是可能罹患之疾病的醫療院所資訊、建議的定期醫療追蹤時程，營養保健品或藥品之實用建議，或 是建議之運動器材選項。 Finally, step 96 is performed. The user can link the personalized health advice 533 of the evaluation recommendation report 53 to the solution platform 6 to directly trade the formula advice of the personalized health advice 533. Here, the formula advice can be Information on medical facilities for possible illnesses, recommended regular medical follow-up schedules, practical advice on nutritional supplements or medicines, or Is the recommended sports equipment option.
實際實施時，若該使用者覺得頻尿，可登入該使用者介面平台1，並在該需求資料介面21上輸入“頻尿？”的病症相關需求提問，過程中該使用者可利用文字欄位、或語音欄位方式輸入需求提問，之後該使用者介面平台1對需求提問的關鍵字“頻尿”與該個人化資料庫3中有異常的生理數據進行比對，得知該使用者可能罹患之疾病對應有腎病變(ACE)、糖尿病(ADRB2)、泌尿系統(CASR)等基因，進一步地，作出上述可能罹患之疾病的計分如下表2、3，及4，由總分排名可能造成頻尿的原因為腎病變>泌尿系統>糖尿病，因此，該健康分析資料51列出權重比例分析排名為1.腎病變2.泌尿系統3.糖尿病。 In actual implementation, if the user feels frequent urination, he can log in to the user interface platform 1 and enter a "frequency urination?" Disease-related requirement question on the demand data interface 21. In the process, the user can use the text field Input demand question by way of bit or voice field, and then the user interface platform 1 compares the keyword "frequency urine" of demand question with abnormal physiological data in the personalized database 3 to learn that the user Possible diseases include kidney disease (ACE), diabetes (ADRB2), urinary system (CASR) and other genes. Further, the scores for the possible diseases mentioned above are given in Tables 2, 3, and 4, which are ranked by the total score. The possible cause of frequent urination is nephropathy> urinary system> diabetes. Therefore, the health analysis data 51 lists the weight ratio analysis ranking as 1. renal disease 2. urinary system 3. diabetes.
同時該使用者介面平台1針對該需求提問的關鍵字“頻尿”與該醫學與健康資料庫4之醫學與健康相關資料41進行相關比對，搜尋出相關可能產生此現象之原因，以得到該醫學相關資料52。然後，該使用者介面平台1將該健康分析資料51與該醫學相關資料52進行相關 比對，本發明於比對過程中統整了該使用者的基因檢測結果31、即時的日常健康數據32、歷史的醫療數據33等先天與後天的生理數據，以得到多面向且專屬之評估建議報告53供該使用者參考。 At the same time, the keyword "frequency urine" of the user interface platform 1 asking the question is compared with the medical and health-related data 41 of the medical and health database 4, and the relevant reasons for this phenomenon are searched to obtain The medical related information 52. Then, the user interface platform 1 correlates the health analysis data 51 with the medical related data 52 For comparison, the present invention integrates the user ’s genetic test results 31, real-time daily health data 32, historical medical data 33 and other innate and acquired physiological data during the comparison process to obtain a multi-faceted and exclusive evaluation Report 53 is recommended for reference by the user.
較佳地，該評估建議報告53之疾病風險評估531會說明該使用者可能是因腎病變或泌尿系統引起頻尿症狀，其可能罹患之疾病為腎病變比例63%、泌尿系統疾病28%、糖尿病9%的權重比例分析，而該病徵說明532則為腎病變或泌尿系統引起頻尿之關聯性原因說明，另外，該個人化健康建議533則提供日常生活、飲食、運動，及定期醫療追蹤資訊等配方建議。值得一提的是，該使用者由該個人化健康建議533即可連結至該解決方案平台6的配方資料庫61，以直接交易該個人化健康建議533之配方建議，進而提升該使用者使用該配方建議的便利性。 Preferably, the disease risk assessment 531 of the evaluation recommendation report 53 will indicate that the user may have frequent urinary symptoms due to renal disease or urinary system. The possible diseases are 63% of renal disease, 28% of urological disease, A 9% weighting analysis of diabetes, and the symptom description 532 is a related cause of kidney disease or urinary system causing frequent urination. In addition, the personalized health advice 533 provides daily living, diet, exercise, and regular medical follow-up. Information and other recipe suggestions. It is worth mentioning that the user can link to the formula database 61 of the solution platform 6 from the personalized health advice 533 to directly trade the formula advice of the personalized health advice 533, thereby improving the user's use Convenience of this formula.
本發明除了可於該需求資料介面21輸入疾病之需求提問外，亦可僅針對健康徵狀、飲食營養需求、醫療常識、日常生活或運動習慣等進行提問。 In addition to inputting questions about diseases in the demand data interface 21, the present invention can also only ask questions about health symptoms, diet and nutrition needs, medical common sense, daily life, or exercise habits.
於此，再舉一針對健康方面的需求提問實施範例，若另一使用者覺得最近記憶力不佳，則可在該需求資料介面21上輸入“記憶力衰退”的需求提問，該使用者介面平台1對需求提問的關鍵字與該個人化資料庫3進行比對，同時該使用者介面平台1針對關鍵字與該醫學與 健康資料庫4進行相關比對，搜尋出相關可能產生此現象之原因，以得到該醫學相關資料52，然後，該使用者介面平台1將該健康分析資料51與該醫學相關資料52進行相關比對以得到該評估建議報告53。 Here, another example of asking questions about health needs is provided. If another user feels that his memory is not good recently, he can enter a "memory decline" demand question on the demand data interface 21, the user interface platform 1 The keywords for which the question is asked are compared with the personalized database 3, and the user interface platform 1 The health database 4 performs a correlation comparison, searches for related reasons that may cause this phenomenon to obtain the medical related data 52, and then the user interface platform 1 performs a correlation comparison between the health analysis data 51 and the medical related data 52 Right to get the assessment recommendations report53.
由於該使用者的基因檢測結果31、該使用者的日常健康數據32，及該使用者的醫療數據33等數據並無特別異常或超出正常值，所以該使用者可能罹患之疾病計分均為低風險或正常，因此，該評估建議報告53之疾病風險評估531所列出之可能罹患的疾病比例低，該病徵說明532則會針對引起記憶力衰退之關聯性原因說明，而該個人化健康建議533則提供日常記憶力訓練、補充飲食、增加睡眠時間、培養運動習慣等配方建議，以確實解決使用者所提問之健康相關問題。進一步地，透過使用者依需求登入該使用者介面平台1輸入需求提問，不僅可節省使用者前往醫療院所尋求健康諮詢之時間浪費，亦可提升健康隱私之保密性考量。 Since the user's genetic test result 31, the user's daily health data 32, and the user's medical data 33 are not particularly abnormal or exceed normal values, the scores of diseases that the user may suffer from are all Low risk or normal, therefore, the assessment recommends that the proportion of diseases that may be listed in the disease risk assessment 531 of the report 53 is low, the symptom description 532 will explain the related causes of memory loss, and the personalized health recommendation 533 provides formula recommendations such as daily memory training, dietary supplements, increased sleep time, and exercise habits, so as to truly solve the health-related questions asked by users. Further, by logging in to the user interface platform 1 as required by a user to input a question, the user can not only save the time of the user going to the medical institution to seek health consultation, but also improve the confidentiality considerations of health privacy.
綜上所述，本發明互動式智能健康管理系統及其方法，藉由將該需求提問的關鍵字分別與該個人化資料庫3及該醫學與健康資料庫4進行第一次資料比對，再將兩者所得之結果進行第二次資料比對，以作為專屬該使用者的健康評估報告，提升早期發現而免於延誤治療之時機，以達到智能健康管理之目的，故確實可以達成本發 明之目的。 To sum up, the interactive intelligent health management system and method of the present invention perform the first data comparison with the personalized database 3 and the medical and health database 4 respectively by using the keywords of the demand question, The results obtained by the two are then compared for the second time as the exclusive health evaluation report of the user, which improves the early detection and avoids the delay of treatment to achieve the purpose of intelligent health management, so the cost can be achieved. hair Ming purpose.
惟以上所述者，僅為本發明之較佳實施例而已，當不能以此限定本發明實施之範圍，即大凡依本發明申請專利範圍及發明說明內容所作之簡單的等效變化與修飾，皆仍屬本發明專利涵蓋之範圍內。 However, the above are only the preferred embodiments of the present invention. When the scope of implementation of the present invention cannot be limited by this, that is, the simple equivalent changes and modifications made according to the scope of the patent application and the description of the invention, All are still within the scope of the invention patent.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW106146583A TWI680431B (en) | 2017-12-29 | 2017-12-29 | Interactive intelligent health management system and method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW106146583A TWI680431B (en) | 2017-12-29 | 2017-12-29 | Interactive intelligent health management system and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201931294A TW201931294A (en) | 2019-08-01 |
| TWI680431B true TWI680431B (en) | 2019-12-21 |
Family
ID=68315662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW106146583A TWI680431B (en) | 2017-12-29 | 2017-12-29 | Interactive intelligent health management system and method |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI680431B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI704943B (en) * | 2019-12-18 | 2020-09-21 | 遠東科技大學 | Artificial intelligence-assisted adaptive fitness training method |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI854454B (en) * | 2023-01-18 | 2024-09-01 | 孟令士 | A doctor-patient communication assistance system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050095628A1 (en) * | 2003-09-12 | 2005-05-05 | Krempin David W. | Program for regulating health conditions |
| US20110093295A1 (en) * | 2009-09-19 | 2011-04-21 | Mankad Vipul N | Consumer enabling system for personalized health maintenance |
| CN105373984A (en) * | 2015-07-27 | 2016-03-02 | 上海乐怡生物科技有限公司 | Human body health status evaluation system |
| CN105740597A (en) * | 2015-12-10 | 2016-07-06 | 西安时代基因健康科技股份有限公司 | Complex disease inheritance risk parameter detection system |
-
2017
- 2017-12-29 TW TW106146583A patent/TWI680431B/en active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050095628A1 (en) * | 2003-09-12 | 2005-05-05 | Krempin David W. | Program for regulating health conditions |
| US20110093295A1 (en) * | 2009-09-19 | 2011-04-21 | Mankad Vipul N | Consumer enabling system for personalized health maintenance |
| CN105373984A (en) * | 2015-07-27 | 2016-03-02 | 上海乐怡生物科技有限公司 | Human body health status evaluation system |
| CN105740597A (en) * | 2015-12-10 | 2016-07-06 | 西安时代基因健康科技股份有限公司 | Complex disease inheritance risk parameter detection system |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI704943B (en) * | 2019-12-18 | 2020-09-21 | 遠東科技大學 | Artificial intelligence-assisted adaptive fitness training method |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201931294A (en) | 2019-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US Preventive Services Task Force et al. | Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement | |
| Manrai et al. | In the era of precision medicine and big data, who is normal? | |
| Mokdad et al. | Correction: actual causes of death in the United States, 2000 | |
| Mangione et al. | Screening for prediabetes and type 2 diabetes in children and adolescents: US preventive services task force recommendation statement | |
| Stuss et al. | Do long tests yield a more accurate diagnosis of dementia than short tests?: A comparison of 5 neuropsychological tests | |
| Kravitz et al. | Recall of recommendations and adherence to advice among patients with chronic medical conditions | |
| Walter et al. | Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization | |
| Cabana et al. | Why don't physicians follow clinical practice guidelines?: A framework for improvement | |
| Hansen et al. | Underdiagnosis of hypertension in children and adolescents | |
| Church et al. | Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes | |
| Blair et al. | The fitness, obesity, and health equation: is physical activity the common denominator? | |
| Whelan et al. | Pain and satisfaction with pain control in hospitalized medical patients: no such thing as low risk | |
| Amarasingham et al. | Clinical information technologies and inpatient outcomes: a multiple hospital study | |
| Hajjar et al. | Impact of diet on blood pressure and age-related changes in blood pressure in the US population: analysis of NHANES III | |
| Legorreta et al. | Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience | |
| Guendelman et al. | Improving asthma outcomes and self-management behaviors of inner-city children: a randomized trial of the Health Buddy interactive device and an asthma diary | |
| Pollack et al. | Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales | |
| Valbuena et al. | Racial and ethnic bias in pulse oximetry and clinical outcomes | |
| Killeen et al. | Objectively measured visual impairment and dementia prevalence in older adults in the US | |
| Lindenauer et al. | Quality of care for patients hospitalized with heart failure: assessing the impact of hospitalists | |
| Baughman et al. | Adherence to American cancer society nutrition and physical activity guidelines among cancer survivors | |
| Chong et al. | Association between breastfeeding and likelihood of myopia in children | |
| Megwalu | Health literacy in patients with head and neck cancer: an understudied issue | |
| Levinstein et al. | Yield of routine annual laboratory tests in a skilled nursing home population | |
| Ebbeling et al. | Tracking pediatric obesity: an index of uncertainty? |